RSBN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.724000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.984200E-01
Normal-vs-Stage2
6.010000E-02
Normal-vs-Stage3
1.937020E-01
Normal-vs-Stage4
7.867000E-01
Stage1-vs-Stage2
4.270400E-01
Stage1-vs-Stage3
3.268300E-02
Stage1-vs-Stage4
5.221400E-01
Stage2-vs-Stage3
1.075320E-03
Stage2-vs-Stage4
1.200410E-01
Stage3-vs-Stage4
8.140000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.516500E-02
Normal-vs-AfricanAmerican
7.797200E-01
Normal-vs-Asian
1.092960E-01
Caucasian-vs-AfricanAmerican
4.934300E-02
Caucasian-vs-Asian
4.689200E-01
AfricanAmerican-vs-Asian
9.571800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.678300E-02
Normal-vs-Female
1.199780E-01
Male-vs-Female
2.723000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.040400E-01
Normal-vs-Age(41-60Yrs)
2.034400E-01
Normal-vs-Age(61-80Yrs)
5.153800E-02
Normal-vs-Age(81-100Yrs)
2.592800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.572200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.161800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.786400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.347580E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.277100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.052400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.632000E-02
Normal-vs-Daily Drinker
5.263500E-02
Normal-vs-Weekly Drinker
1.524190E-02
Normal-vs-Occasional Drinker
2.961000E-01
Normal-vs-Social Drinker
2.627200E-01
Non Drinker-vs-Daily Drinker
7.443800E-01
Non Drinker-vs-Weekly Drinker
1.859970E-01
Non Drinker-vs-Occasional Drinker
5.941600E-02
Non Drinker-vs-Social Drinker
2.015600E-01
Daily Drinker-vs-Weekly Drinker
1.362190E-01
Daily Drinker-vs-Occasional Drinker
1.412050E-01
Daily Drinker-vs-Social Drinker
3.513600E-01
Weekly Drinker-vs-Occasional Drinker
1.256270E-02
Weekly Drinker-vs-Social Drinker
5.128400E-02
Occasional Drinker-vs-Social Drinker
7.127400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.455800E-02
Normal-vs-Grade 2
1.565910E-02
Normal-vs-Grade 3
1.151900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.158000E-01
Grade 1-vs-Grade 3
4.698800E-01
Grade 1-vs-Grade 4
6.455800E-02
Grade 2-vs-Grade 3
4.056200E-01
Grade 2-vs-Grade 4
1.565910E-02
Grade 3-vs-Grade 4
1.151900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.297800E-01
Normal-vs-NonDiabetic
4.034500E-02
Diabetic-vs-NonDiabetic
5.934800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.774500E-02
Normal-vs-NoPancreatitis
4.186200E-02
Pancreatitis-vs-NoPancreatitis
6.130200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.431590E-01
Normal-vs-N1
5.416100E-02
N0-vs-N1
9.112600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.139800E-01
Normal-vs-TP53-NonMutant
3.347000E-01
TP53-Mutant-vs-TP53-NonMutant
1.128580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
